KJ-104

N/A

Report date: 2022/05/10 11:40:59

Base Information

Drug NameKJ-104
Drug Alias NameKJ104
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsCytokine Release Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKisoji Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesKisoji Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsCytokine Release Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A